Myelinated dorsal root ganglion cultures activate both the alternative and classical pathways of complement

Journal of the Neurological Sciences

Volumn 165, Issue 2, 1999, Pages 160-169

  Scott Zaki, Patricia ^a   Purkall, Donald ^a   Bigbee, John ^a   Ruddy, Shaun ^a   Yu, Robert K ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Antibody; Complement; Demyelination; Dorsal root ganglion; Glycolipids; Rodent

Indexed keywords

ANTIBODY; COMPLEMENT; GLYCOLIPID;

ANIMAL TISSUE; ARTICLE; COMPLEMENT ACTIVATION; DEMYELINATING DISEASE; DEMYELINATION; EMBRYO; ENZYME IMMUNOASSAY; HEMOLYSIS; IMMUNOHISTOCHEMISTRY; NONHUMAN; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL; RAT; SERUM; SPINAL GANGLION; TISSUE CULTURE;

ANIMALS; BUFFERS; COMPLEMENT ACTIVATION; COMPLEMENT PATHWAY, ALTERNATIVE; COMPLEMENT PATHWAY, CLASSICAL; COMPLEMENT SYSTEM PROTEINS; CULTURE MEDIA; GALACTOSYLCERAMIDES; GANGLIA, SPINAL; GUINEA PIGS; HEMOLYSIS; HUMANS; IMMUNOENZYME TECHNIQUES; NERVE FIBERS, MYELINATED; PARAPROTEINEMIAS; RATS;

EID: 0033150307     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-510X(99)00104-5     Document Type: Article

References (51)

1. Albers J.W., Kelly J.J.J. Acquired inflammatory demyelinating polyneuropathies: clinical and electrodiagnostic features. Muscle Nerve. 12:1989;435-451.
2. Monaco S., Bonetti B., Ferrari S., Moretto G., Nardelli E., Tedesco F., Mollnes T.E., Nobille-Orazio E., Manfredini E., Bonazzi L., Rizzuto N. Complement-mediated demyelination in patients with IgM monoclonal gammopathy and polyneuropathy. N Engl J Med. 322:(10):1990;649-652.
3. Hays A.P., Lee S.L.S., Latov N. Immune reactive C3d on the surface of myelin sheaths in neuropathy. J Neuroimmunol. 18:(3):1988;231-244.
4. Latov N., Gross R.B., Kastleman J., Flanagan T., Lamme S., Alkaitis D.A., Olarte M.R., Sherman W.H., Chess L., Penn A.S. Complement-fixing anti-peripheral nerve myelin antibodies in patients with inflammatory polyneuritis and with polyneuropathy and paraproteinemia. Neurology. 31:1981;1530-1534.
5. Koski C. Characterization of complement-fixing antibodies to peripheral nerve myelin in Guillain-Barre syndrome. Ann Neurol. 27s:1990;S44-S47.
6. Saida T., Saida K., Lisak R.P., Brown M.J., Silberberg D.H., Asbury A.K. In vitro demyelinating activity of sera from patients with Guillain-Barre syndrome. Ann Neurol. 11:1982;69-75.
7. Feasby T.E., Hahn A.F., Gilbert J.J. Passive transfer studies in Guillain-Barre polyneuropathy. Neurology. 32:1982;1159-1167.
8. Sawant-Mane S., Clark M.B., Koski C. In vitro demyelination by serum antibody from patients with Guillain-Barre syndrome requires terminal complement complexes. Ann Neurol. 29:(4):1991;397-404.
9. Harrison B.M., Hansen L.A., Pollard J.D., McLeod J.G. Demyelination induced by serum from patients with Guillain-Barre syndrome. Ann Neurol. 15:1984;163-170.
10. Sumner A.J., Saida K., Saida T. Acute conduction block associated with experimental antiserum-mediated demyelination of peripheral nerve. Ann Neurol. 11:1982;469-477.
11. Saida T., Saida K., Silberberg D.H., Brown M.J. Experimental allergic neuritis induced by galactocerebroside. Ann Neurol. 9:(Suppl):1981;87-101.
12. Maeda Y., Bigbee J.W., Maeda R., Miyatani N., Kalb R.G., Yu R.K. Induction of demyelination by intraneural injection of antibodies against sulfoglucuronyl paragloboside. Exp Neurol. 113:1991;221-225.
13. Low P.A., Schmelzer J.D., Dyck P.J. Results of endoneural injection of Guillain-Barre serum in Lewis rats. Mayo Clin Proc. 57:1982;360-364.
14. Tandon D.S., Griffin J.W., Drachman D.B. Studies on the humoral mechanisms of inflammatory demyelinating neuropathies. Neurology. 30:1980;362.
15. Chou K.H., Nolan C.E., Jungalwala F.B. Subcellular fractionation of rat sciatic nerve and specific localization of ganglioside LM1 in rat nerve myelin. J Neurochem. 44:1985;1898-1912.
16. Guzman-Harty M., Warner J.K., Mancini M.E., Pearl D.K., Yates A.J. Effect of crush lesion on ganglioside radiolabelling patterns in rat sciatic nerve. J Neuropathol Exp Neurol. 49:1990;225-236.
17. Klein F., Mandel P. Gangliosides of the peripheral nervous system of the rat. Life Sci. 16:1975;751-758.
18. Chou K.H., Nolan C.E., Jungalwala F.B. Composition and metabolism of gangliosides in rat peripheral nervous system during development. J Neurochem. 38:1982;1547-1558.
19. Oshima H., Soma G., Mizuno D. Gangliosides can activate human alternative complement pathway. Int Immunol. 5:1993;1349-1351.
20. Nobille-Orazio E., McIntosh C., Latov N. Anti-MAG antibody and antibody complexes: detection by radioimmunoassay. Neurology. 35:1985;988-992.
21. Griffith L.S., Schmitz B., Schachner M. L2/HNK-1 carbohydrate and protein-protein interactions mediate the homophilic binding of the neural adhesion molecule P0. J Neurosci Res. 33:1992;639-648.
22. Snipes G.J., Suter U., Shooter E.M. Human peripheral myelin protein-22 carries the L2/HNK-1 carbohydrate adhesion epitope. J Neurochem. 61:(5):1993;1961-1964.
23. Ariga T., Kohriyama T., Freddo L., Latov N., Saito M., Kon K., Ando S., Suzuki M., Hemling M.E., Rinehart K.L., Kusunoki S., Yu R.K. Characterization of sulfate glucuronic acid containing glycolipids reacting with IgM-M proteins in patients with neuropathy. J Biol Chem. 262:1987;848-853.
24. Chou D.K.H., Ilyas A.A., Evans J.E., Costello C., Quarles R.H., Jungalwala F.B. Structure of sulfated glucuronyl glycolipids in the nervous system reacting with HNK-1 antibody and some IgM paraproteins in neuropathy. J Biol Chem. 261:1986;11717-11725.
25. Freddo L., Ariga T., Saito M., Macala L.C., Yu R.K., Latov N. The neuropathy of plasma cell dyscrasia: binding of IgM M-protein to peripheral nerve glycolipids. Neurology. 35:1985;1420-1424.
26. Ilyas A.A., Dalakas M.C., Brady R.O., Quarles R.H. Sulfated glucuronosyl glycolipids reacting with anti-myelin associated glycoprotein monoclonal antibodies including IgM paraproteins in neuropathy: species distribution and partial characterization of epitopes. Brain Res. 385:1986;1-9.
27. Ilyas A.A., Quarles R.H., MacIntosh T.D., Dobersen M.J., Trapp B.D., Dalakas M.C., Brady R.O. IgM in a human neuropathy related to paraproteinemia binds to a carbohydrate determinant in the myelin associated glycoprotein and to a ganglioside. Proc Natl Acad Sci USA. 81:1984;1225-1229.
28. Brockes J., Patt M. Studies on cultured rat Schwann cells: derivation of purified populations from cultures of peripheral nerve. Brain Res. 165:1979;105-118.
29. Gupta J.J., Bigbee J.W. Substratum-induced modulation of acetylcholinesterase activity in cultured dorsal root ganglion neurons. J Neurosci Res. 31:1992;454-461.
30. Bigbee J.W., Foster R.E. Freeze fracture analysis of the axolemma of cultured dorsal root ganglion neurons in the absence of Schwann cells. Brain Res. 494:1989;182-186.
31. Eldridge C.F., Bunge M.B., Bunge R.P., Wood P.M. Differentiation of axon related Schwann cells in vitro. I. Ascorbic acid regulates basal lamina assembly and myelin formation. J Cell Biol. 105:1987;1023-1034.
32. Braun P., Frail D., Latov N. MAG is the antigen for a monoclonal antibody in patients with demyelinating neuropathy. J Neurochem. 39:1982;1261-1265.
33. Kent J.F., Fife E.H. Precise standardization of reagents for complement fixation. Am J Trop Med. 12:1963;103.
34. Scott P. Interactions of thrombospondin with the alternative complement pathway. 1994;48-49 Virginia Commonwealth University.
35. Folch J., Lees M., Stanley G.H.S. A simple method for the isolation and purification of total lipids from animal tissues. J Biol Chem. 226:1957;497-509.
36. Nelson B. Description and partial characterization of an accessory factor which participates in the hemolysis of rabbit erythrocytes by the human alternative complement pathway. 1977;32 Virginia Commonwealth University.
37. O'Shannessy D.J., Willison H.J., Inuzuka T., Dobersen M.J., Quarles R.H. The species distribution of nervous system antigens that react with anti-myelin-associated glycoprotein antibodies. J Neuroimmunol. 9:1985;255-268.
38. Galili U., Shohet S.B., Kobrin E., Stults C.L.M., Macher B.A. Man, apes, and Old World monkeys differ from other mammals in the expression of α-galactosyl epitopes on nucleated cells. J Biol Chem. 263:1988;17755-17762.
39. Galili U., Clark M.R., Shohet S.B., Buehler J., Macher B.A. Evolutionary relationship between the anti-Gal antibody and the Galα(1,3)Gal epitope in primates. Proc Natl Acad Sci USA. 84:1987;1369-1373.
40. Parker W., Bruno D. Characterization and affinity purification of xenoreactive human natural antibodies. J Immunol. 153:1994;3791-3803.
41. Galili U. Evolution and pathophysiology of the human natural anti-α-galactosyl IgG (anti-Gal) antibody. Springer Semin Immunopathol. 15:1993;155-171.
42. Galili U., Macher B.A., Buehler J., Shohet S.B. Human natural anti-α-galactosyl IgG: II. The specific recognition of α(1,3)-linked galactose residues. J Exp Med. 62:1985;573-578.
43. Galili U., Rachmilewitz E.A., Peleg A., Flechner I. A unique natural human IgG antibody with anti-α-galactosyl specificity. J Exp Med. 160:1984;1519-1531.
44. Funabashi K., Okada N., Matsuo S., Yamamoto T., Morgan B.P., Okada H. Tissue distribution of complement regulatory membrane proteins in rats. Immunology. 81:1994;444-451.
45. Powell M.B., Marchbank K.J., Rushmere N.K., van den Berg C.W., Morgan B.P. Molecular cloning, chromosomal localization, expression, and functional characterization of the mouse analogue of human CD59. J Immunol. 158:1997;1692-1702.
46. Rushmere N.K., Tomlinson S., Morgan B.P. Expression of rat CD59: functional analysis confirms lack of species selectivity and reveals that glycosylation is not required for function. Immunology. 90:1997;640-646.
47. Gasque P., Morgan B.P. Complement regulatory protein expression by a human oligodendrocyte cell line: cytokine regulation and comparison with astrocytes. Immunology. 89:1996;338-347.
48. Dubois-Dalque M., Buyse M., Buyse G., Gorce F. The action of Guillian-Barre syndrome serum on myelin: a tissue culture and electron microscopic analysis. J Neurol Sci. 13:1971;67-83.
49. Mithen F.A., Ilyas A.A., Birchem R., Cook S.D. Effects of Guillain-Barre sera containing antibodies against glycolipids in cultures of rat Schwann cells and sensory neurons. J Neurol Sci. 112:1992;223-232.
50. LaVecchio J.A., Dunne A.D., Edge A.S.B. Enzymatic removal of alpha-galactosyl epitopes from porcine endothelial cells diminishes the cytotoxic effect of natural antibodies. Transplantation. 60:1995;841-847.
51. Li R., Ladisch S. Inhibition of endogeneous ganglioside synthesis does not block neurite formation by retinoic acid-treated neuroblastoma cells. J Biol Chem. 272:1997;1349-1354.